Production of IBDV VP2 in highly immunogenic form
A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural prote...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FAHEY KEVIN J JAGADISH MITTUR N HEINE HANS-GEORG CHAPMAN ANTONY J AZAD AHMED A VAUGHAN PAUL R MACREADIE IAN G MCKERN NEIL M |
| description | A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural protein in a yeast or other eukaryotic host cell. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5614409A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5614409A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5614409A3</originalsourceid><addsrcrecordid>eNrjZDAMKMpPKU0uyczPU8hPU_B0cglTCAswUsjMU8jITM_IqVTIzM0tzctPT83LTFZIyy_K5WFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8aHBpmaGJiYGlo7GhFUAAHe9KgA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Production of IBDV VP2 in highly immunogenic form</title><source>esp@cenet</source><creator>FAHEY; KEVIN J ; JAGADISH; MITTUR N ; HEINE; HANS-GEORG ; CHAPMAN; ANTONY J ; AZAD; AHMED A ; VAUGHAN; PAUL R ; MACREADIE; IAN G ; MCKERN; NEIL M</creator><creatorcontrib>FAHEY; KEVIN J ; JAGADISH; MITTUR N ; HEINE; HANS-GEORG ; CHAPMAN; ANTONY J ; AZAD; AHMED A ; VAUGHAN; PAUL R ; MACREADIE; IAN G ; MCKERN; NEIL M</creatorcontrib><description>A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural protein in a yeast or other eukaryotic host cell.</description><edition>6</edition><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1997</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19970325&DB=EPODOC&CC=US&NR=5614409A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19970325&DB=EPODOC&CC=US&NR=5614409A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FAHEY; KEVIN J</creatorcontrib><creatorcontrib>JAGADISH; MITTUR N</creatorcontrib><creatorcontrib>HEINE; HANS-GEORG</creatorcontrib><creatorcontrib>CHAPMAN; ANTONY J</creatorcontrib><creatorcontrib>AZAD; AHMED A</creatorcontrib><creatorcontrib>VAUGHAN; PAUL R</creatorcontrib><creatorcontrib>MACREADIE; IAN G</creatorcontrib><creatorcontrib>MCKERN; NEIL M</creatorcontrib><title>Production of IBDV VP2 in highly immunogenic form</title><description>A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural protein in a yeast or other eukaryotic host cell.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1997</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAMKMpPKU0uyczPU8hPU_B0cglTCAswUsjMU8jITM_IqVTIzM0tzctPT83LTFZIyy_K5WFgTUvMKU7lhdLcDPJuriHOHrqpBfnxqcUFicmpeakl8aHBpmaGJiYGlo7GhFUAAHe9KgA</recordid><startdate>19970325</startdate><enddate>19970325</enddate><creator>FAHEY; KEVIN J</creator><creator>JAGADISH; MITTUR N</creator><creator>HEINE; HANS-GEORG</creator><creator>CHAPMAN; ANTONY J</creator><creator>AZAD; AHMED A</creator><creator>VAUGHAN; PAUL R</creator><creator>MACREADIE; IAN G</creator><creator>MCKERN; NEIL M</creator><scope>EVB</scope></search><sort><creationdate>19970325</creationdate><title>Production of IBDV VP2 in highly immunogenic form</title><author>FAHEY; KEVIN J ; JAGADISH; MITTUR N ; HEINE; HANS-GEORG ; CHAPMAN; ANTONY J ; AZAD; AHMED A ; VAUGHAN; PAUL R ; MACREADIE; IAN G ; MCKERN; NEIL M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5614409A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1997</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>FAHEY; KEVIN J</creatorcontrib><creatorcontrib>JAGADISH; MITTUR N</creatorcontrib><creatorcontrib>HEINE; HANS-GEORG</creatorcontrib><creatorcontrib>CHAPMAN; ANTONY J</creatorcontrib><creatorcontrib>AZAD; AHMED A</creatorcontrib><creatorcontrib>VAUGHAN; PAUL R</creatorcontrib><creatorcontrib>MACREADIE; IAN G</creatorcontrib><creatorcontrib>MCKERN; NEIL M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FAHEY; KEVIN J</au><au>JAGADISH; MITTUR N</au><au>HEINE; HANS-GEORG</au><au>CHAPMAN; ANTONY J</au><au>AZAD; AHMED A</au><au>VAUGHAN; PAUL R</au><au>MACREADIE; IAN G</au><au>MCKERN; NEIL M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Production of IBDV VP2 in highly immunogenic form</title><date>1997-03-25</date><risdate>1997</risdate><abstract>A highly immunogenic form of the VP2 structural protein of IBDV comprises a high molecular weight aggregated form of VP2 produced by the expression of a nucleotide sequence coding for the VP2 structural protein or a polypeptide displaying the antigenicity of all or a part of the VP2 structural protein in a yeast or other eukaryotic host cell.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US5614409A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Production of IBDV VP2 in highly immunogenic form |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T05%3A46%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FAHEY;%20KEVIN%20J&rft.date=1997-03-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5614409A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |